Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Data on cancer vaccines described by researchers at University of Nijmegen, Nijmegen Center for Molecular Life Science
May 27th, 2008
Investigators publish new data in the report 'Dendritic cell vaccines in melanoma: from promise to proof.' "Dendritic cells (DC) are the directors of the immune system, capable of inducing tumor antigen-specific T-and B-cell responses. As such, they are currently applied in clinical studies in cancer patients," scientists in Netherlands report. "Early small clinical trials showed promising results, with frequent induction of anti-cancer immune reactivity and clinical responses. In recent years, additional trials have been carried out in melanoma patients, and although immunological responses are often reported, objective clinical responses remain anecdotal with...
Source: Cancer Weekly (2008-05-27)
|
